MedCost Clearmedcostclear.com · data checked Nov 15, 2026
GLP-1 coverage denied: appeal routes and deadlines by coverage type
From federal rules, CMS and HealthCare.gov pages and model notices. General information, not legal or medical advice.
May be out of date — see https://medcostclear.com/insurance/glp1-denial-appeal/
- A known change date has passed since this sheet was built.
Read the notice for three things
- Who denied it: a Medicare drug plan, the Medicare GLP-1 Bridge, a Marketplace or individual plan, a job-based plan (self-funded or insured), or Medicaid (a managed care plan or the state).
- The reason: not on the drug list; prior authorization criteria not met; step therapy; quantity limit; a plan exclusion; not medically necessary; or (Medicare) excluded because it is for weight loss.
- The date printed on the notice: every deadline counts from it or from the day it arrived.
Deadlines by coverage type[1][2][3][4][5][6][7][8]
| Coverage | First appeal: deadline | Decision time | Next level |
|---|---|---|---|
| Medicare Part D / Medicare Advantage with drugs | Redetermination: 65 days from the date on the notice | 7 days; fast 72 hours | Independent Review Entity, 65 days |
| Marketplace / individual plan | Internal appeal (one level): 180 days | 30 days (60 if already paid); urgent 72 hours | External review within 4 months; decided in 45 days (72 hours urgent) |
| Job-based plan | Internal appeal: at least 180 days | 30 days (60 if already paid); urgent 72 hours | External review within 4 months |
| Medicaid managed care | Plan appeal: 60 days from the date on the notice | 30 days; fast 72 hours | State fair hearing, 90 to 120 days (state sets) |
| Medicaid fee-for-service | State fair hearing: state sets, at most 90 days from mailing | State rules | — |
| Medicare GLP-1 Bridge | Prescriber resubmits the prior authorization for re-review | — | — |
If the notice gives a shorter deadline, follow the notice.
Medicare Part D: exceptions
- The plan sends a "Notice of Denial of Medicare Part D Drug Coverage" (form CMS-10146). It shows the date of the notice and the reason.[1]
- An exception is a special kind of request: a formulary exception (the drug is not on the list), a coverage rule exception (prior authorization, quantity limit, step therapy) or a tiering exception. The prescriber must send a supporting statement.[1][9]
- The plan decides an exception within 72 hours (24 hours if fast) after it gets the prescriber's statement.[10][11]
Exclusions: be honest with your client
- A plan or state exclusion of weight-loss drugs usually can't be overturned by an appeal; federal external review covers denials that involve medical judgment.[5][12]
- Medicare excludes drugs when used for weight loss; for weight management the Medicare route is the GLP-1 Bridge. A use Part D covers (heart risk, sleep apnea, type 2 diabetes) goes to the Part D plan.[13][14]
- Self-funded job-based plans are not subject to state insurance laws (so state step therapy laws don't apply to them).[15]
Free help
- SHIP (Medicare counseling): SHIPhelp.org or 1-877-839-2675. Job-based plans: Employee Benefits Security Administration, 1-866-444-3272. Federal external review (HHS process): 1-888-866-6205.[1][16][17]
Official sources (date our archive last confirmed each one)
- CMS-10146 Notice of Denial of Medicare Part D Drug Coverage. https://www.cms.gov/files/zip/notice-denial-part-d-prescription-drug-cvg-english-form-instructs-cms-10146-eff-010125.zip — checked Nov 15, 2026
- CMS: Reconsideration by the Part D Independent Review Entity. https://www.cms.gov/medicare/appeals-grievances/prescription-drug/reconsiderations — checked Nov 15, 2026
- 29 CFR 2560.503-1 (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-29?part=2560§ion=2560.503-1 — checked Nov 15, 2026
- HealthCare.gov: Internal appeals. https://www.healthcare.gov/appeal-insurance-company-decision/internal-appeals/ — checked Nov 15, 2026
- 45 CFR 147.136 (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-45?part=147§ion=147.136 — checked Nov 15, 2026
- 42 CFR Part 438, Subpart F (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=438&subpart=F — checked Nov 15, 2026
- 42 CFR Part 431, Subpart E (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=431&subpart=E — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge information for prescribers. https://www.cms.gov/files/document/glp-1-prescribers-c-1.pdf — checked Nov 15, 2026
- CMS: Exceptions (Part D). https://www.cms.gov/medicare/appeals-grievances/prescription-drug/exceptions — checked Nov 15, 2026
- 42 CFR Part 423, Subpart M (eCFR). https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=423&subpart=M — checked Nov 15, 2026
- CMS: Coverage Determinations (Part D). https://www.cms.gov/medicare/appeals-grievances/prescription-drug/coverage-determinations — checked Nov 15, 2026
- 42 U.S.C. 1396r-8 (GovInfo). https://www.govinfo.gov/content/pkg/USCODE-2023-title42/html/USCODE-2023-title42-chap7-subchapXIX-sec1396r-8.htm — checked Nov 15, 2026
- 42 U.S.C. 1395w-102 (GovInfo). https://www.govinfo.gov/content/pkg/USCODE-2023-title42/html/USCODE-2023-title42-chap7-subchapXVIII-partD-subpart1-sec1395w-102.htm — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- U.S. Department of Labor, Technical Release 2014-01. https://www.dol.gov/agencies/ebsa/employers-and-advisers/guidance/technical-releases/14-01 — checked Nov 15, 2026
- HHS/DOL model notice of final internal adverse benefit determination. https://www.cms.gov/files/document/final-internal-adverse-benefit-determination-model-standard.docx — checked Nov 15, 2026
- CMS: HHS-Administered Federal External Review Process. https://www.cms.gov/cciio/programs-and-initiatives/consumer-support-and-information/csg-ext-appeals-facts — checked Nov 15, 2026
Current version: https://medcostclear.com/insurance/glp1-denial-appeal/ · Sheet built Nov 15, 2026. How we keep it current: archived daily; flagged after 7 days without a check; copied by hand (the site blocks automated copies); flagged after 90 days.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.